Search for: "TEVA PHARMACEUTICAL INDUSTRIES LIMITED" Results 1 - 20 of 136
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Aug 2016, 2:11 pm by Lawrence B. Ebert
Teva plans to appeal to the United States Court of Appeals for the Federal Circuitlink: http://finance.yahoo.com/news/teva-confirms-ptab-decisions-two-214600255.htmlBack on Jan. 28, 2014, Teva Pharmaceutical Industries Ltd.announced that the U.S. [read post]
1 Dec 2011, 7:40 pm by Rantanen
By Jason Rantanen Teva Pharmaceutical Industries Ltd. v. [read post]
18 Aug 2013, 8:54 pm by Patent Docs
Teva Biopharmaceuticals USA, Inc. et al. 2:13-cv-04911; filed August 12, 2013 in the District Court of New Jersey • Plaintiffs: Amgen Inc.; Amgen Manufacturing, Limited • Defendants: Teva Biopharmaceuticals USA, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
9 Oct 2009, 9:11 am
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
11 Sep 2012, 5:30 am by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
12 Oct 2018, 1:24 pm by Lawrence B. Ebert
Delaware of invalidity of claims:Plaintiffs-Appellants Teva Pharmaceuticals USA,Inc., Teva Pharmaceutical Industries, Ltd., Teva Neuroscience,Inc., and Yeda Research and Development Co. [read post]
10 Oct 2011, 10:00 am by Lucas A. Ferrara, Esq.
FTC Requires Sale of Generic Cancer Pain Drug and Muscle Relaxant as Conditions of Teva's $6.8 Billion Acquisition of Cephalon Par Pharmaceuticals Will Acquire Drug Assets, Enter Agreement To Make Generic Provigil To protect competition in the market for prescription drugs, the Federal Trade Commission will require Teva Pharmaceutical Industries Ltd. to sell the rights and assets related to a generic cancer pain drug and a generic muscle relaxant,… [read post]
15 May 2019, 5:27 am by Kluwer Patent blogger
’ ‘Defendant Teva is a consistent participant in the conspiracies identified in this Complaint, but the conduct is pervasive and industry-wide. [read post]
6 Jan 2014, 6:45 am by David Jensen
He said pharmaceutical makers such as Teva Pharmaceutical Industries Ltd. [read post]
13 Oct 2014, 9:01 am by Lyle Denniston
  The company has a reputation in the industry of moving aggressively to protect its monopoly advantage, even suing the FDA at one point — unsuccessfully. [read post]
3 Mar 2012, 6:48 am by Max Kennerly, Esq.
The original for this post is New Jersey Supreme Court Re-affirms Discovery Rule For Statute of Limitations in Pharmaceutical Negligence Lawsuits at Litigation & Trial Lawyer Blog.Some of the largest drug companies in the United States are based in, of have their U.S. headquarters in, New Jersey — e.g., Johnson & Johnson is in New Brunswick, Merck is in Whitehouse Station, Roche is in Nutley, Barr (now owned by Teva) is in Montvale, Sanofi is in Bridgewater… [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
Teva Pharmaceuticals Industries Ltd. and Teva Pharmaceuticals USA, Inc. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
28 Mar 2014, 5:33 pm
   Procedural History"Defendants-Appellants Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Lupin, Ltd.; Lupin Pharmaceuticals, Inc.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and Mylan… [read post]
21 Apr 2023, 9:05 pm by Laura Dolbow
In 2017, Teva Pharmaceuticals submitted an application to market a generic version of Korlym. [read post]
17 Jul 2014, 10:58 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.; Sun… [read post]
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical… [read post]
30 Jun 2014, 10:28 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.; Sun… [read post]
22 Mar 2016, 4:00 am by Paula Bremner
The annual US Generic Pharmaceutical Association meeting in February, despite being held in Orlando, was generally not a sunny affair. [read post]